Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals

被引:27
|
作者
An, Panpan [1 ]
Li, Jiexin [1 ]
Lu, Linlin [1 ]
Wu, Yingmin [1 ]
Ling, Yuyi [1 ]
Du, Jun [1 ]
Chen, Zhuojia [2 ]
Wang, Hongsheng [1 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangdong Prov Key Lab New Drug Design & Evaluat, Guangzhou 510006, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
TNBC; Migration; HDAC8; YAP; TRANSCRIPTION; HDAC8; PROTEIN;
D O I
10.1016/j.ejphar.2018.12.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Triple-negative breast cancer (TNBC) shows highly aggressive clinical behaviors and poor prognosis compared to other breast cancer subtypes. Histone deacetylases (HDACs) can regulate the progression of various cancers, but the role of HDAC8 in TNBC remains unexplored. Here, we found that HDAC8 enhanced the in vitro migration abilities of breast cancer cells. Targeted inhibition of HDAC8 via si-HDAC8 and its selective inhibitor PCI34051 could suppress the migration of cells. In TNBC cells, HDAC8 stabilized the expression and increased the nuclear localization of YAP, a major downstream effector of Hippo pathway. While silencing YAP could attenuate HDAC8 triggered migration of TNBC cells. Mechanistically, HDAC8 suppressed the phosphorylation of YAP(ser127), which was related to its cytoplasmic sequestration degradation. Our data revealed that HDAC8 could trigger the migration of TNBC cells via regulation of Hippo-YAP signals, suggesting that HDAC8 might be a potential target for TNBC therapy.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 50 条
  • [11] Molecular profiling basal 2 subtypes of triple-negative breast cancer cells and their response to histone deacetylase inhibitor
    Lyn-Cook, Beverly
    Stovall, Destiny
    Word, Beverly
    Cotton, Ebony
    Hammons, George
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [12] Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
    Yanrong Su
    Nathan R. Hopfinger
    Theresa D. Nguyen
    Thomas J. Pogash
    Julia Santucci-Pereira
    Jose Russo
    Journal of Experimental & Clinical Cancer Research, 37
  • [13] Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer
    Hsieh, Chang-Lin
    Ma, Hon-Ping
    Su, Chih-Ming
    Chang, Yu-Jia
    Hung, Wan-Yu
    Ho, Yuan-Soon
    Huang, Wei-Jan
    Lin, Ruo-Kai
    LIFE SCIENCES, 2016, 151 : 7 - 14
  • [14] IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells via Regulation of Hippo Pathways
    Hou, Lingmi
    Xie, Shaoli
    Li, Guanwu
    Xiong, Bin
    Gao, Yanchun
    Zhao, Xiaobo
    Hu, Jiani
    Deng, Shishan
    Jiang, Jun
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (05) : 549 - 557
  • [15] Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization
    Chen, Wei
    Bai, Yuxin
    Patel, Chrishma
    Geng, Fei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 520 (02) : 263 - 268
  • [16] Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells
    Liu, Qiuyu
    van der Stel, Wanda
    van der Noord, Vera E.
    Leegwater, Hanneke
    Coban, Bircan
    Elbertse, Kim
    Pruijs, Joannes T. M.
    Bequignon, Olivier J. M.
    van Westen, Gerard
    Le Devedec, Sylvia E.
    Danen, Erik H. J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [17] Unexpected selectivity of histone deacetylase inhibitors in live MDA-MD-231 triple-negative breast cancer cells
    Aboukhatwa, Shaimaa M.
    Hanigan, Thomas W.
    Neerasa, Jayaprakash
    Taha, Taha Y.
    Brown, Nathan D.
    El-Bastawissy, Eman E.
    Elkersh, Mohamed A.
    El-Moselhy, Tarek F.
    Frasor, Jonna
    Petukhov, Pavel A.
    CANCER RESEARCH, 2018, 78 (13)
  • [18] Treatment with Histone Deacetylase Inhibitors Creates 'BRCAness' and Sensitizes Human Triple Negative Breast Cancer Cells to PARP Inhibitors and Cisplatin
    Bhalla, K. N.
    Rao, R.
    Sharma, P.
    Das Gupta, S.
    Chauhan, L.
    Stecklein, S.
    Fiskus, W.
    CANCER RESEARCH, 2012, 72
  • [19] Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression
    Xu, Pengfei
    Xiong, Wei
    Lin, Yun
    Fan, Liping
    Pan, Hongchao
    Li, Yaochen
    CELL DEATH & DISEASE, 2021, 12 (08)
  • [20] Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression
    Pengfei Xu
    Wei Xiong
    Yun Lin
    Liping Fan
    Hongchao Pan
    Yaochen Li
    Cell Death & Disease, 12